ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ INHIBITOR, FOR THE TREATMENT OF PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES (CITADEL‐101) von Caimi, P., Ramchandren, R., Phillips, T.J., Wertheim, M.S., Gutierrez, M.E., Edenfield, W.J., Akard, L.P., Call, J.A., Persky, D.O., DeMarini, D.J., Zhou, L., Yeleswaram, S., Forero‐Torres, A.

Volltext

Slow platelet recovery after PBPC transplantation from unrelated donors von Jansen, J, Hanks, S G, Akard, L P, Morgan, J A, Nolan, P L, Dugan, M J, Reeves, M I, Thompson, J M

Volltext

303: Role of Extensive Splenomegaly in Patients with Myelofibrosis undergoing a Reduced Intensity Allogeneic Stem Cell Transplant von Ciurea, S.O, Sadegi, B, Wilbur, A, Alagiozian-Angelova, V, Gaitonde, S, Dobogai, L, Akard, L.P, Hoffman, R, Rondelli, D

Volltext

Impaired PBPC collection in patients with myeloma after high-dose melphalan von Jansen, J., Thompson, J.M., Dugan, M.J., Wiemann, M.C., Hanks, S., Greenspan, A.R., Akard, L.P.

Volltext

Ursodiol-based prophylaxis for veno-occlusive disease (VOD): A retrospective risk-based review of outcomes following allogeneic stem cell transplantation von Thompson, J.M., Akard, L.P., Dugan, M.J., English, K., Jansen, J.

Volltext

Twice-weekly ABLC prophylaxis for patients at high risk of invasive fungal infection after allogeneic stem cell transplantation von Jansen, J., Akard, L.P., Wack, M.F., Thompson, J.M., Dugan, M.J., Leslie, J.K., Mattison, R.H.

Volltext